| answer text |
<p>Through the Accelerated Access Review, the NHS Long Term Plan and the second Life
Sciences Sector Deal, the Government and the National Health Service have confirmed
their commitment that, where appropriate, all patients should be able to benefit from
the best treatments as fast as possible. To deliver on this, we have announced a number
of measures to improve the spread of health tech innovations:</p><p> </p><p>- Strengthening
the Innovation Scorecard, the national tool that measures the uptake of cost effective
innovations approved by the National Institute for Health and Care Excellence (NICE),
and widening the range of medtech products it covers;</p><p>- From 2020, a new NHS
England health tech funding requirement will identify the best value innovations as
‘ready to spread’ and help the NHS to adopt them quickly. This will apply to health
tech products assessed as cost saving by NICE. In addition, NICE will significantly
increase the number of evaluations it does for health tech products, so that the NHS
has the evidence it needs to decide the best products to adopt and spread;</p><p>-
The Accelerated Access Collaborative, under the chairmanship of Lord Darzi, will be
expanded to be the umbrella organisation across the innovation landscape in the United
Kingdom, tackling the system wide-barriers that cause unwarranted variation in the
level of access for patients;</p><p>- The regional network of Academic Health Science
Networks (AHSNs) will also continue to be a key partner in adoption and spread of
health technology. AHSNs bring together the assets in their regions to drive innovation
uptake and support local service transformation, promoting health equality, best practice
and transformation in leadership, quality and safety of care; and</p><p>- These approaches
build on NHS Improvement’s Getting It Right First Time and NHS RightCare initiatives,
which seek to improve the quality of care within the NHS by reducing unwarranted variation.</p>
|
|
